Search - tctmd.com

Displaying 621 - 640 of 769

Sort: Relevancy | Date

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Daily News

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Yael L. Maxwell

April 12, 2013

News Daily News

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

L.A. McKeown

April 05, 2013

News Industry News

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

March 11, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

L.A. McKeown

March 11, 2013

News Industry News

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

March 09, 2013

News Daily News

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

Caitlin E. Cox

March 03, 2013

News Daily News

La Intervención Transcatéter Válvula Mitral dentro de Otra Válvula es Buena para los Pacientes Inoperables

Caitlin E. Cox

March 03, 2013

News Daily News

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

February 28, 2013

News Daily News

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

February 28, 2013

News Industry News

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

February 27, 2013

News Daily News

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Jason Kahn

January 28, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

Low BMI Predicts Stroke, Death After TAVR

November 28, 2012

News Industry News

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

November 15, 2012

News Daily News

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

Caitlin E. Cox

November 12, 2012

News Daily News

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

Caitlin E. Cox

November 12, 2012

News Conference News TCT 2012

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

October 31, 2012

Advertisement

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Post-TAVR Infection Reported in 1 of 5 Patients But Not Linked with Mortality

Percutaneous Mitral Commissurotomy Shows Long-term Success, Even with Reintervention

Survival of SAPIEN High-Risk Patients Equivalent to Surgery at Three Years

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

German Valve Registry Shows Advantage of Surgery in Lower Risk Patients

Lower-Profile SAPIEN XT Transcatheter Heart Valve Associated With Improved Procedural Outcomes

Transcatheter Mitral Valve-in-Valve Procedure Benefits Inoperable Patients

La Intervención Transcatéter Válvula Mitral dentro de Otra Válvula es Buena para los Pacientes Inoperables

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

Medtronic Announces CE Mark for Engager™ Transcatheter Valve

STS Meeting Looks at New TAVR Device and Reviews Valve Procedure Rates in the UK

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Low BMI Predicts Stroke, Death After TAVR

First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

La TAVR Transfemoral, no la Transapical es Más Rentable que la Cirugía

TAVR Feasible for Inoperable Patients with Severe Regurgitation Alone

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content